People with psoriasis, an autoimmune disorder marked by itchy, red patches of skin, appear to have a 50% increased risk of developing Sjögren’s syndrome, according to an analysis of medical records involving nearly 600,000 people. The risk of developing Sjögren’s was even higher…
News
Treatment with Evoxac (cevimeline hydrochloride) significantly improved salivary flow and eased symptoms of dry mouth in people with Sjögren’s syndrome, according to a meta-analysis of three clinical trials. These findings suggest that Evoxac, an approved Sjögren’s treatment, is a “promising therapeutic option, particularly for individuals with mild to moderate…
Problems with regulatory T-cells, or Tregs — a type of immune cell that plays a key role in dampening the body’s immune responses — drives the development of Sjögren’s disease, according to a recent mouse study. Treg dysfunction, also demonstrated by the genetic signatures in immune cells isolated from…
People with primary Sjögren’s disease and neuropathic pain — pain caused by damage or dysfunction of the nervous system — are more likely to experience lower urinary tract problems than those without neuropathic pain. That’s according to a study in Turkey, which also found that neuropathic pain appeared to…
Ainos is partnering with Taiwan Tanabe Seiyaku, a subsidiary of Mitsubishi Tanabe Pharma, to advance the manufacturing and promotion of its investigational low-dose formulation of interferon alpha for Sjögren’s disease in Taiwan. Both parties will clarify the details of the partnership in a formal agreement. According to Ainos,…
Drinking a traditional Chinese medicinal tea led to improvements in tear production, reductions in ocular dryness, and better sleep quality in patients with Sjögren’s disease, a study shows. Sjögren’s patients also reported a significant reduction in using artificial tears, from a…
Johnson & Johnson’s antibody-based therapy candidate nipocalimab has been granted breakthrough therapy designation by the U.S. Food and Drug Administration (FDA) for treating adults with moderate to severe Sjögren’s disease. This status is meant to accelerate the development and regulatory review of investigational therapies intended to treat serious…
Blood levels of antibodies against aquaporin 5 (anti-AQP5) — a protein that regulates water movement in tissues — may be used as a biomarker to diagnose primary Sjögren’s disease, a study…
Blood levels of transthyretin (TTR) may be used as a biomarker to predict and monitor disease activity in people with primary Sjögren’s disease, a study in China suggests. TTR is a protein that transports thyroxine, the main hormone secreted by the thyroid gland, to the liver and brain. It’s…
A web-based tool to assess daily symptoms of Sjögren’s disease is easy to implement, was well accepted, and effectively captures the high day-to-day symptom variability among patients, a three-month pilot study shows. Data collected with the web app PEPSS over a pre-specified period differed from that captured with standard,…
Recent Posts
- Global trial testing oral Sjögren’s treatment seeking over 300 patients
- Lung decline stays steady despite rise in Sjögren’s ILD treatment
- Older Sjögren’s patients may face more lung issues, study reports
- Sjögren’s patients at higher risk for new, repeat infections
- Inflammatory markers in blood may help identify people with Sjögren’s
- Study links serious cardiovascular events to higher death risk in Sjögren’s
- Inflammatory protein may distinguish Sjögren’s disease subtype: Study
- Global campaign aims to raise awareness of Sjögren’s disease
- Upcoming trial to test experimental antibody therapy for Sjögren’s
- Intermittent fasting might protect eyes in Sjögren’s by shifting gut bacteria